Adding Nivolumab to Induction Chemotherapy Safe in Younger AML Patients
This video highlights a phase II trial that tested the addition of nivolumab to combination induction chemotherapy of cytarabine and idarubicin for patients with newly diagnosed acute myeloid leukemia.
Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
In this interview ahead of the ASH Annual Meeting we discuss the current management of Philadelphia chromosome–positive acute lymphoblastic leukemia and the role of stem cell transplantation.
2 Clarke Drive Cranbury, NJ 08512